$24.83
+0.10 (+0.40%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+19.15%
1Y
+77.87%
YTD
+52.61%
Open$25.41
Previous Close$24.73
Day High$25.74
Day Low$24.24
52W High$27.30
52W Low$12.58
Volume—
Avg Volume1.54M
Market Cap3.90B
P/E Ratio—
EPS$-2.97
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.67
Above
SMA 200
$15.96
Above
RSI (14)
42.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+208.3% upside
Current
$24.83
$24.83
Target
$76.55
$76.55
$56.04
$76.55 avg
$105.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 267.02M | 243.47M | 233.58M |
| Net Income | 59.27M | 48.26M | 42.10M |
| Profit Margin | 22.2% | 19.8% | 18.0% |
| EBITDA | 80.54M | 76.00M | 71.04M |
| Free Cash Flow | 42.58M | 43.55M | 31.33M |
| Rev Growth | -5.4% | -1.1% | +3.4% |
| Debt/Equity | 0.51 | 0.57 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |